Literature DB >> 10388917

Using outlier events to monitor test turnaround time.

S J Steindel1, D A Novis.   

Abstract

OBJECTIVES: To determine the causes of excessive test turnaround time (TAT) and to identify methods of improvement by studying reasons for those tests reported in excess of 70 minutes from the time the test was ordered (ie, outliers).
DESIGN: Self-directed data-gathering of stat outlier TAT events from intensive care units and emergency departments, with descriptive parameters associated with each event and additional descriptive parameters associated with the participant. PARTICIPANTS: Laboratories enrolled in the 1996 College of American Pathologists Q-Probes program. MAIN OUTCOME MEASURES: Components associated with outlier TAT events and outlier TAT rates.
RESULTS: Four hundred ninety-six hospital laboratories returned data on 218 551 stat tests, of which 10.6% had TATs in excess of 70 minutes. Ten percent of stat emergency department tests and 14.7% of stat intensive care unit tests were outliers. Major areas in which delays occurred were test ordering, 29.9%; within-laboratory (analytic) phase, 28.2%; collection of the specimen, 27.4%; postanalytic phase, 1.9%; and undetermined, 12.5%. The type of test performed was a significant factor and was independent of location: Chemistry-Multiple Test appeared most frequently ( approximately 40%), followed closely by Hematology-Complete Blood Count (approximately 20%) and Chemistry-Single Test ( approximately 18%). Factors of outlier TAT components for intensive care unit specimens were identified using statistical modeling and included hour of day, type of health care personnel collecting specimen, performing the test in a stat laboratory, and reason for delay. Outlier rates were not associated with any identified factors. The practice parameters of laboratories with outlier rates in the lowest 10th percentile significantly differed from those with rates in the top 10th percentile in test request computerization, report methods, and ordering methods.
CONCLUSIONS: We observed that outlier analysis yields new information, such as type of test and reason for delay, concerning test delays when compared with TAT determination alone. Laboratories experiencing stat test TAT problems should use this tool as an adjunct to routine TAT monitoring for identifying unique causes of delay.

Entities:  

Mesh:

Year:  1999        PMID: 10388917     DOI: 10.5858/1999-123-0607-UOETMT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  An Audit of VDRL Testing from an STI Clinic in India: Analysing the Present Scenario with Focus on Estimating and Optimizing the Turnaround Time.

Authors:  Bhanu Mehra; Preena Bhalla; Deepti Rawat; Shikhar Saxena
Journal:  J Clin Diagn Res       Date:  2015-08-01

2.  Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus.

Authors:  M F Q Kluytmans-van den Bergh; M C Vos; B M W Diederen; C M J E Vandenbroucke-Grauls; A Voss; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-27       Impact factor: 3.267

3.  Laboratory turnaround time.

Authors:  Robert C Hawkins
Journal:  Clin Biochem Rev       Date:  2007-11

Review 4.  Turnaround Time (TAT): Difference in Concept for Laboratory and Clinician.

Authors:  Hara P Pati; Gurmeet Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-08       Impact factor: 0.900

5.  Monitoring and root cause analysis of clinical biochemistry turn around time at an academic hospital.

Authors:  Kiran P Chauhan; Amit P Trivedi; Dharmik Patel; Bhakti Gami; N Haridas
Journal:  Indian J Clin Biochem       Date:  2013-11-20

Review 6.  Mapping turnaround times (TAT) to a generic timeline: a systematic review of TAT definitions in clinical domains.

Authors:  Bernhard Breil; Fleur Fritz; Volker Thiemann; Martin Dugas
Journal:  BMC Med Inform Decis Mak       Date:  2011-05-24       Impact factor: 2.796

7.  National survey on intra-laboratory turnaround time for some most common routine and stat laboratory analyses in 479 laboratories in China.

Authors:  Yang Fei; Rong Zeng; Wei Wang; Falin He; Kun Zhong; Zhiguo Wang
Journal:  Biochem Med (Zagreb)       Date:  2015-06-05       Impact factor: 2.313

Review 8.  Turnaround Time: An Efficacy Measure for Medical Laboratories.

Authors:  Pratibha P Dawande; Rashmi S Wankhade; Faizan I Akhtar; Obaid Noman
Journal:  Cureus       Date:  2022-09-06

9.  Laboratory-based clinical audit as a tool for continual improvement: an example from CSF chemistry turnaround time audit in a South-African teaching hospital.

Authors:  Lucius C Imoh; Mubanga Mutale; Christopher T Parker; Rajiv T Erasmus; Annalise E Zemlin
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

10.  Therapeutic turnaround times for common laboratory tests in a tertiary hospital in Kenya.

Authors:  Thomas Mwogi; Tim Mercer; Dan N Tina Tran; Ronald Tonui; Thorkild Tylleskar; Martin C Were
Journal:  PLoS One       Date:  2020-04-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.